AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Back to search results

Mithramycin analogues and their application against Ewing sarcoma - 2004

Technology Benefits
Aberrantregulation of FLI1 as well as other transcription factors (eg ERG) areimplicated in several cancers and often result in malignant transformations. Acharacteristic of Ewing Sarcoma involves a chromosomal translocation resultingin a chimeric EWS-FLI1 fusion protein. Mithramycin has been identified as apotent inhibitor of EWS-FLI1, but has also proved to be highly toxic tonon-sarcoma cells. To address this, Rohr and colleagues have created MTManalogues to improve the performance, selectivity, and efficacy of MTM.
Detailed Technology Description
None
*Abstract
None
Country/Region
USA

For more information, please click Here
Mobile Device